SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+12.64%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$703M
AUM Growth
+$703M
(+24%)
Cap. Flow
+$36.3M
Cap. Flow
% of AUM
5.16%
Top 10 Holdings %
Top 10 Hldgs %
37.2%
Holding
186
New
62
Increased
29
Reduced
37
Closed
42
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$25.3M |
| 2 |
AbbVie
ABBV
|
$23.8M |
| 3 |
Merck
MRK
|
$21.6M |
| 4 |
ENDP
Endo International plc
ENDP
|
$18.8M |
| 5 |
Amgen
AMGN
|
$17.8M |
Top Sells
| 1 |
Ormat Technologies
ORA
|
$34.5M |
| 2 |
Novartis
NVS
|
$33.5M |
| 3 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$18.2M |
| 4 |
Biogen
BIIB
|
$12.7M |
| 5 |
ISRL
Isramco Inc
ISRL
|
$11.1M |
Sector Composition
| 1 | Healthcare | 73.44% |
| 2 | Technology | 3.56% |
| 3 | Industrials | 2.47% |
| 4 | Consumer Discretionary | 2.06% |
| 5 | Utilities | 1.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
AstraZeneca
AZN
$255B
| $5.93M | 0.62% |
86,637
| – | – |
|
27
Check Point Software Technologies
CHKP
$20.6B
| $5.9M | 0.61% |
+71,927
| New | +$5.9M |
|
|
INSY
28
DELISTED
Insys Therapeutics, Inc.
INSY
| $5.81M | 0.61% |
+100,000
| New | +$5.81M |
|
|
BLCM
29
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $5.69M | 0.59% |
249,567
-81,947
| -25% | -$1.87M |
|
|
CNCE
30
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $5.68M | 0.59% |
375,000
+225,000
| +150% | +$3.41M |
|
31
Apple
AAPL
$3.54T
| $5.32M | 0.55% |
42,733
-10,070
| -19% | -$1.25M |
|
32
Arbutus Biopharma
ABUS
$753M
| $5.21M | 0.54% |
298,486
+123,486
| +71% | +$2.16M |
|
33
Insmed
INSM
$30.3B
| $5.2M | 0.54% |
+250,000
| New | +$5.2M |
|
34
Kamada
KMDA
$401M
| $5.17M | 0.54% |
293,727
| – | – |
|
|
FWP
35
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $5.1M | 0.53% |
180,000
-20,000
| -10% | -$566K |
|
|
TW
36
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $5.06M | 0.53% |
38,300
-4,050
| -10% | -$535K |
|
37
Vanda Pharmaceuticals
VNDA
$279M
| $5.05M | 0.53% |
543,390
+175,000
| +48% | +$1.63M |
|
38
Amicus Therapeutics
FOLD
$2.42B
| $4.9M | 0.51% |
450,000
-100,000
| -18% | -$1.09M |
|
|
RLYP
39
DELISTED
RELYPSA INC COM
RLYP
| $4.87M | 0.51% |
135,000
+7,900
| +6% | +$285K |
|
40
Catalyst Pharmaceutical
CPRX
$2.42B
| $4.76M | 0.5% |
1,100,000
+40,000
| +4% | +$173K |
|
|
AGTC
41
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $4.7M | 0.49% |
235,124
+70,000
| +42% | +$1.4M |
|
|
IPXL
42
DELISTED
Impax Laboratories, Inc.
IPXL
| $4.69M | 0.49% |
+100,000
| New | +$4.69M |
|
|
MDVN
43
DELISTED
MEDIVATION, INC.
MDVN
| $4.66M | 0.49% |
36,115
-17,000
| -32% | -$2.19M |
|
|
KYTH
44
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $4.51M | 0.47% |
+90,000
| New | +$4.51M |
|
45
Assertio
ASRT
$78M
| $4.48M | 0.47% |
+200,000
| New | +$4.48M |
|
|
BRCM
46
DELISTED
BROADCOM CORP CL-A
BRCM
| $4.36M | 0.45% |
100,800
+12,000
| +14% | +$520K |
|
47
CVS Health
CVS
$93B
| $4.36M | 0.45% |
42,260
+5,650
| +15% | +$583K |
|
48
Health Care Select Sector SPDR Fund
XLV
$33.8B
| $4.34M | 0.45% |
59,853
+11,000
| +23% | +$797K |
|
|
ALXN
49
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $4.33M | 0.45% |
+25,000
| New | +$4.33M |
|
|
ALDR
50
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $4.33M | 0.45% |
150,000
+50,000
| +50% | +$1.44M |
|